Quintiles Transnational has signed an agreement for a joint venture to commercialize pharmaceutical products in the Asia Pacific region. Quintiles’ partners in the joint venture, which will have an investment fund totaling $112 million, are leading Asia Pacific pharmaceutical services group Interpharma Asia Pacific, parent of drug distributor Zuellig Pharma; and Asia investment company Temasek Holdings Ltd. In June 2005, Quintiles’ signed a letter of intent for the joint venture...